[{"address1": "7 Golda Meir Street", "address2": "Weizmann Science Park", "city": "Ness Ziona", "zip": "7403650", "country": "Israel", "phone": "972 8 931 3433", "website": "https://www.sol-gel.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Ms. Tamar  Fishman Jutkowitz", "age": 48, "title": "VP & General Counsel", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 271000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moshe  Arkin", "age": 71, "title": "CEO & Executive Chairman", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eyal  Ben-Or", "age": 41, "title": "Chief Financial Officer", "yearBorn": 1983, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Itzik  Yosef", "age": 48, "title": "Chief Operating Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 236000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Glezin", "age": 42, "title": "Chief Business Officer", "yearBorn": 1982, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.4, "open": 7.3, "dayLow": 7.3, "dayHigh": 7.48, "regularMarketPreviousClose": 7.4, "regularMarketOpen": 7.3, "regularMarketDayLow": 7.3, "regularMarketDayHigh": 7.48, "payoutRatio": 0.0, "beta": 1.097, "forwardPE": -15.273959, "volume": 3658, "regularMarketVolume": 3658, "averageVolume": 34896, "averageVolume10days": 7000, "averageDailyVolume10Day": 7000, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 20423800, "fiftyTwoWeekLow": 3.34, "fiftyTwoWeekHigh": 16.5, "priceToSalesTrailing12Months": 1.6874989, "fiftyDayAverage": 7.29566, "twoHundredDayAverage": 6.786815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4891639, "profitMargins": -1.07775, "floatShares": 689337, "sharesOutstanding": 2785760, "sharesShort": 26269, "sharesShortPriorMonth": 14764, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0094, "heldPercentInsiders": 0.70002997, "heldPercentInstitutions": 0.24292, "shortRatio": 0.97, "shortPercentOfFloat": 0.0228, "impliedSharesOutstanding": 2785760, "bookValue": 7.241, "priceToBook": 1.0124983, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -13044000, "trailingEps": -4.7, "forwardEps": -0.48, "lastSplitFactor": "1:10", "lastSplitDate": 1746403200, "enterpriseToRevenue": 0.404, "enterpriseToEbitda": -0.345, "52WeekChange": -0.19477695, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 7.3315, "recommendationKey": "none", "totalCash": 16902000, "totalCashPerShare": 6.067, "ebitda": -14165250, "totalDebt": 1179000, "quickRatio": 4.545, "currentRatio": 5.124, "totalRevenue": 12103000, "debtToEquity": 5.845, "revenuePerShare": 4.345, "returnOnAssets": -0.26822, "returnOnEquity": -0.49388, "grossProfits": -9198000, "revenueGrowth": 1.212, "grossMargins": -0.75998, "ebitdaMargins": -1.17039, "operatingMargins": -8.796309, "financialCurrency": "USD", "symbol": "SLGL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1751390894, "exchange": "NCM", "messageBoardId": "finmb_621569", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.9256762, "regularMarketPrice": 7.3315, "shortName": "Sol-Gel Technologies Ltd.", "longName": "Sol-Gel Technologies Ltd.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1517495400000, "regularMarketChange": -0.06850004, "regularMarketDayRange": "7.3 - 7.48", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 34896, "fiftyTwoWeekLowChange": 3.9915001, "fiftyTwoWeekLowChangePercent": 1.1950599, "fiftyTwoWeekRange": "3.34 - 16.5", "fiftyTwoWeekHighChange": -9.1685, "fiftyTwoWeekHighChangePercent": -0.5556667, "fiftyTwoWeekChangePercent": -19.477695, "earningsTimestamp": 1747998900, "earningsTimestampStart": 1755174600, "earningsTimestampEnd": 1755520200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -4.7, "epsForward": -0.48, "fiftyDayAverageChange": 0.035840034, "fiftyDayAverageChangePercent": 0.0049125142, "twoHundredDayAverageChange": 0.5446849, "twoHundredDayAverageChangePercent": 0.08025633, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Sol-Gel", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]